To develop and validate a non-invasive, in vivo, phenotyping method for CYP2D6 using the
non-injurious neuroselective electrical stimulation technique: pain perception threshold/pain
tolerance threshold (PPT/PTT) in children and adolescents with sickle cell disease.
Phase:
Phase 4
Details
Lead Sponsor:
Children's National Research Institute Children's Research Institute